Denise Pfingstler-Johnson
Nurse Practitioner · du Bois, PANPI 1962979336
Payments from drug & device makers
Across 348 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Travere Therapeutics, Inc.$793
- AstraZeneca$662
- Bayer$579
- OPKO Pharmaceuticals, LLC$576
- Amgen$555
- Novartis$535
- plus $3K from 26 others
What the payments were for
- Consulting fees$1502%
- Speaking & faculty fees$2254%
- Food & beverage$5,90094%
- Education$331%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Travere Therapeutics, Inc. | 58 | $793 |
| AstraZeneca(2 entities) | 32 | $662 |
| Bayer | 42 | $579 |
| OPKO Pharmaceuticals, LLC | 34 | $576 |
| Amgen | 33 | $555 |
| Novartis | 16 | $535 |
| Aurinia Pharma U.S., Inc. | 13 | $331 |
| Calliditas Therapeutics US Inc. | 14 | $292 |
| Otsuka America Pharmaceutical, Inc. | 13 | $240 |
| Mallinckrodt Hospital Products Inc. | 9 | $172 |
| Fresenius USA Marketing, Inc. | 9 | $172 |
| Kyowa Kirin, Inc. | 7 | $168 |
| Daiichi Sankyo Inc. | 13 | $166 |
| Akebia Therapeutics Inc | 7 | $135 |
| GSK | 8 | $127 |
| Vifor Pharma, Inc. | 5 | $119 |
| Boehringer Ingelheim | 6 | $117 |
| Ardelyx, Inc. | 5 | $96 |
| Pfizer | 3 | $64 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $56 |
| Shield Therapeutics Inc | 3 | $54 |
| Johnson & Johnson | 3 | $49 |
| Novo Nordisk | 2 | $38 |
| Cumberland Pharmaceuticals, Inc. | 1 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Sanofi | 1 | $25 |
| Bard Peripheral Vascular, Inc. | 1 | $24 |
| Apellis Pharmaceuticals, Inc. | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Athena Bioscience, LLC | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,308 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 140 | $157,321 |
| KerendiaFinerenone | 131 | $129,231 |
| JardianceEmpagliflozin | 25 | $37,143 |
| Cinacalcet Hcl | 83 | $35,050 |
| OzempicSemaglutide | 35 | $32,779 |
| Repatha SyringeEvolocumab | 25 | $15,505 |
| VeltassaPatiromer Calcium Sorbitex | 12 | $13,893 |
| Calcitriol | 525 | $10,062 |
| Clonidine | 47 | $9,531 |
| Potassium Chloride | 139 | $5,658 |
| Allopurinol | 429 | $4,860 |
| Potassium Citrate ErPotassium Citrate | 33 | $4,489 |
| Valsartan | 179 | $3,504 |
| Famotidine | 221 | $3,087 |
| Rosuvastatin Calcium | 49 | $1,714 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $662 | $157,321140 claims |
| BayerKerendia | $579 | $129,231131 claims |
| Boehringer IngelheimJardiance | $117 | $37,14325 claims |
| Novo NordiskOzempic | $38 | $32,77935 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $19 | $3,504179 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in du Bois
- Jean Levindu Bois$15K
- Todd Sudikdu Bois$11K
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.